nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An imputation method for calculating and comparing autoimmune disease incidence using partial case review
|
Slezak, Jeff |
|
2017 |
35 |
48PB |
p. 6672-6675 4 p. |
artikel |
2 |
A novel multi-variant epitope ensemble vaccine against avian leukosis virus subgroup J
|
Wang, Xiaoyu |
|
2017 |
35 |
48PB |
p. 6685-6690 6 p. |
artikel |
3 |
Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia
|
Mehta, Parinda A. |
|
2017 |
35 |
48PB |
p. 6712-6719 8 p. |
artikel |
4 |
A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066)
|
Frey, Sharon E. |
|
2017 |
35 |
48PB |
p. 6759-6765 7 p. |
artikel |
5 |
A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su
|
Strezova, Ana |
|
2017 |
35 |
48PB |
p. 6700-6706 7 p. |
artikel |
6 |
Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria
|
Perraut, Ronald |
|
2017 |
35 |
48PB |
p. 6720-6726 7 p. |
artikel |
7 |
Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain
|
Ly, Hoai J. |
|
2017 |
35 |
48PB |
p. 6634-6642 9 p. |
artikel |
8 |
Cost-effectiveness of mass dog rabies vaccination strategies to reduce human health burden in Flores Island, Indonesia
|
Wera, Ewaldus |
|
2017 |
35 |
48PB |
p. 6727-6736 10 p. |
artikel |
9 |
Editorial Board/Aims and Scope
|
|
|
2017 |
35 |
48PB |
p. IFC- 1 p. |
artikel |
10 |
Effect of recombinant glutathione S-transferase as vaccine antigen against Rhipicephalus appendiculatus and Rhipicephalus sanguineus infestation
|
Sabadin, Gabriela Alves |
|
2017 |
35 |
48PB |
p. 6649-6656 8 p. |
artikel |
11 |
Enhancing the role of vaccines in combatting antimicrobial resistance
|
Clift, Charles |
|
2017 |
35 |
48PB |
p. 6591-6593 3 p. |
artikel |
12 |
Episode of Kasabach-Merritt phenomenon following Japanese encephalitis vaccination: Case report
|
Yue, Xiaojie |
|
2017 |
35 |
48PB |
p. 6594-6597 4 p. |
artikel |
13 |
European Court of Justice ruling on vaccine liability and its implications for the United States
|
Yang, Y. Tony |
|
2017 |
35 |
48PB |
p. 6583-6584 2 p. |
artikel |
14 |
Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid
|
Bernstein, Henry H. |
|
2017 |
35 |
48PB |
p. 6707-6711 5 p. |
artikel |
15 |
Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model
|
Wheat, William H. |
|
2017 |
35 |
48PB |
p. 6611-6619 9 p. |
artikel |
16 |
Induction of a balanced IgG1/IgG2 immune response to an experimental challenge with Mycoplasma bovis antigens following a vaccine composed of Emulsigen™, IDR peptide1002, and poly I:C
|
Prysliak, Tracy |
|
2017 |
35 |
48PB |
p. 6604-6610 7 p. |
artikel |
17 |
Induction of lung CD8+ T cell responses by consecutive inoculations of a poly(I:C) influenza vaccine
|
Moriyama, Miyu |
|
2017 |
35 |
48PB |
p. 6620-6626 7 p. |
artikel |
18 |
Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges
|
Hu, Zenglei |
|
2017 |
35 |
48PB |
p. 6585-6590 6 p. |
artikel |
19 |
Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal
|
Katz, Joanne |
|
2017 |
35 |
48PB |
p. 6743-6750 8 p. |
artikel |
20 |
Patterns of childhood immunization and all-cause mortality
|
McCarthy, Natalie L. |
|
2017 |
35 |
48PB |
p. 6643-6648 6 p. |
artikel |
21 |
Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal
|
Hughes, Michelle M. |
|
2017 |
35 |
48PB |
p. 6766-6773 8 p. |
artikel |
22 |
Projections of zoster incidence in Australia based on demographic and transmission models of varicella-zoster virus infection
|
Costantino, Valentina |
|
2017 |
35 |
48PB |
p. 6737-6742 6 p. |
artikel |
23 |
Reactogenicity and safety assessment of an attenuated nanovaccine against scorpion envenomation: Preclinical study
|
Nait Mohamed, Faez Amokrane |
|
2017 |
35 |
48PB |
p. 6657-6663 7 p. |
artikel |
24 |
Recruitment barriers for prophylactic vaccine trials: A study in Belgium
|
Harrington, Lauriane |
|
2017 |
35 |
48PB |
p. 6598-6603 6 p. |
artikel |
25 |
Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects
|
Griffin, Paul |
|
2017 |
35 |
48PB |
p. 6676-6684 9 p. |
artikel |
26 |
The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children
|
Walter, Emmanuel B. |
|
2017 |
35 |
48PB |
p. 6664-6671 8 p. |
artikel |
27 |
The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China
|
Lu, Ying |
|
2017 |
35 |
48PB |
p. 6627-6633 7 p. |
artikel |
28 |
The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells
|
Wohlgemuth, Nicholas |
|
2017 |
35 |
48PB |
p. 6691-6699 9 p. |
artikel |
29 |
Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices
|
Wallace, Aaron S. |
|
2017 |
35 |
48PB |
p. 6751-6758 8 p. |
artikel |